Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PTC Therapeutics, Inc. PTCT

Full chart Compare
Set alert

Price alert · PTCT

All alert types
65.40 USD -0.27 (-0.41%)

Nov 6, 2026, 9:43 AM EST

65.18 Day range 66.32
58.80 52-week range 90.87
YTD
-13.90%
1 year
-9.90%

Financial health

Altman Z-Score

0.87 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E 8.9×
FY 2016: -2.6×FY 2017: -8.3×FY 2018: -12.5×FY 2019: -11.2×FY 2020: -9.2×FY 2021: -5.4×FY 2022: -4.9×FY 2023: -3.3×FY 2024: -9.5×FY 2025: 8.9×
FY 2016 5y median -4.9× FY 2025
P/S 3.5×
FY 2016: 4.5×FY 2017: 3.4×FY 2018: 6.0×FY 2019: 9.2×FY 2020: 10.6×FY 2021: 5.2×FY 2022: 3.9×FY 2023: 2.2×FY 2024: 4.3×FY 2025: 3.5×
FY 2016 5y median 3.9× FY 2025
P/B -29.4×
FY 2016: 3.1×FY 2017: 4.2×FY 2018: 4.6×FY 2019: 4.8×FY 2020: 8.4×FY 2021: 1952×FY 2022: -7.9×FY 2023: -2.5×FY 2024: -3.2×FY 2025: -29.4×
FY 2016 5y median -3.2× FY 2025
P/FCF 14.7×
FY 2016: -3.5×FY 2017: -49.6×FY 2018: -37.0×FY 2019: -19.6×FY 2020: -16.1×FY 2021: -8.3×FY 2022: -5.4×FY 2023: -7.4×FY 2024: -19.1×FY 2025: 14.7×
FY 2016 5y median -7.4× FY 2025
EV/EBITDA 8.7×
FY 2016: -1.8×FY 2017: -13.0×FY 2018: -17.0×FY 2019: -14.7×FY 2020: -14.0×FY 2021: -10.6×FY 2022: -10.7×FY 2023: -11.2×FY 2024: -42.8×FY 2025: 8.7×
FY 2016 5y median -10.7× FY 2025
EV/Sales 4.5×
FY 2016: 2.9×FY 2017: 3.1×FY 2018: 5.8×FY 2019: 9.3×FY 2020: 11.1×FY 2021: 7.2×FY 2022: 5.6×FY 2023: 3.9×FY 2024: 6.4×FY 2025: 4.5×
FY 2016 5y median 5.6× FY 2025
FCF Yield 6.8%
FY 2016: -28.4%FY 2017: -2.0%FY 2018: -2.7%FY 2019: -5.1%FY 2020: -6.2%FY 2021: -12.0%FY 2022: -18.6%FY 2023: -13.5%FY 2024: -5.2%FY 2025: 6.8%
FY 2016 5y median -12.0% FY 2025

Profitability

Gross Margin 95.9%
FY 2016: -42.2%FY 2017: 97.6%FY 2018: 95.2%FY 2019: 96.0%FY 2020: 95.0%FY 2021: 94.0%FY 2022: 93.6%FY 2023: 93.0%FY 2024: 92.9%FY 2025: 95.9%
FY 2016 5y median 93.6% FY 2025
Operating Margin 49.5%
FY 2016: -159.7%FY 2017: -33.1%FY 2018: -43.7%FY 2019: -78.6%FY 2020: -113.4%FY 2021: -69.5%FY 2022: -64.0%FY 2023: -46.9%FY 2024: -37.5%FY 2025: 49.5%
FY 2016 5y median -46.9% FY 2025
Net Margin 39.4%
FY 2016: -171.8%FY 2017: -40.6%FY 2018: -48.4%FY 2019: -82.0%FY 2020: -115.1%FY 2021: -97.3%FY 2022: -80.0%FY 2023: -66.8%FY 2024: -45.0%FY 2025: 39.4%
FY 2016 5y median -66.8% FY 2025
ROE -332.5%
FY 2016: -118.8%FY 2017: -50.5%FY 2018: -36.5%FY 2019: -42.3%FY 2020: -90.9%FY 2021: -36432.6%FY 2022: 161.1%FY 2023: 76.6%FY 2024: 33.1%FY 2025: -332.5%
FY 2016 5y median 33.1% FY 2025
ROIC 33.4%
FY 2016: -60.1%FY 2017: -20.8%FY 2018: -12.0%FY 2019: -17.1%FY 2020: -22.3%FY 2021: -22.7%FY 2022: -30.8%FY 2023: -26.3%FY 2024: -21.7%FY 2025: 33.4%
FY 2016 5y median -22.7% FY 2025
ROA 23.5%
FY 2016: -52.8%FY 2017: -20.2%FY 2018: -11.4%FY 2019: -15.5%FY 2020: -19.8%FY 2021: -27.0%FY 2022: -32.8%FY 2023: -33.1%FY 2024: -21.3%FY 2025: 23.5%
FY 2016 5y median -27.0% FY 2025

Growth (YoY)

Revenue 114.5%
FY 2016: 124.9%FY 2017: 135.0%FY 2018: 36.2%FY 2019: 16.0%FY 2020: 24.0%FY 2021: 41.4%FY 2022: 29.7%FY 2023: 34.2%FY 2024: -14.0%FY 2025: 114.5%
FY 2016 FY 2025
Operating Income 383.1%
FY 2016: 21.0%FY 2017: 51.3%FY 2018: -79.9%FY 2019: -108.5%FY 2020: -79.0%FY 2021: 13.3%FY 2022: -19.5%FY 2023: 1.8%FY 2024: 31.2%FY 2025: 383.1%
FY 2016 FY 2025
EPS (diluted) 264.5%
FY 2016: 17.8%FY 2017: 51.6%FY 2018: -36.1%FY 2019: -55.3%FY 2020: -55.5%FY 2021: -11.9%FY 2022: -4.8%FY 2023: -7.4%FY 2024: 43.5%FY 2025: 264.5%
FY 2016 FY 2025
Free Cash Flow 326.0%
FY 2016: 17.1%FY 2017: 87.5%FY 2018: -227.9%FY 2019: -233.7%FY 2020: -73.6%FY 2021: -34.6%FY 2022: -51.2%FY 2023: 45.2%FY 2024: 34.8%FY 2025: 326.0%
FY 2016 FY 2025

Financial Health

Current Ratio 2.3×
FY 2016: 5.3×FY 2017: 3.0×FY 2018: 1.9×FY 2019: 3.3×FY 2020: 4.4×FY 2021: 1.9×FY 2022: 1.7×FY 2023: 2.0×FY 2024: 2.4×FY 2025: 2.3×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 2.3×
FY 2016: 5.3×FY 2017: 2.9×FY 2018: 1.8×FY 2019: 3.2×FY 2020: 4.4×FY 2021: 1.8×FY 2022: 1.7×FY 2023: 2.0×FY 2024: 2.3×FY 2025: 2.3×
FY 2016 5y median 2.0× FY 2025
Debt / Equity -13.2×
FY 2016: 0.8×FY 2017: 0.9×FY 2018: 0.4×FY 2019: 0.6×FY 2020: 0.9×FY 2021: 883×FY 2022: -4.2×FY 2023: -2.7×FY 2024: -2.3×FY 2025: -13.2×
FY 2016 5y median -2.7× FY 2025
Net Debt / EBITDA 1.9×
FY 2016: 1.0×FY 2017: 1.0×FY 2018: 0.8×FY 2019: -0.2×FY 2020: -0.7×FY 2021: -2.9×FY 2022: -3.2×FY 2023: -4.9×FY 2024: -14.0×FY 2025: 1.9×
FY 2016 5y median -3.2× FY 2025
Interest Coverage 5.6×
FY 2016: -16.0×FY 2017: -5.3×FY 2018: -9.2×FY 2019: -19.3×FY 2020: -7.7×FY 2021: -4.4×FY 2022: -4.9×FY 2023: -3.4×FY 2024: -1.8×FY 2025: 5.6×
FY 2016 5y median -3.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31